Q2 Earnings Estimate for HRTX Issued By HC Wainwright
Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) – Equities researchers at HC Wainwright issued their Q2 2025 earnings per share estimates for shares of Heron Therapeutics in a report released on Monday, June 9th. HC Wainwright analyst B. Folkes forecasts that the biotechnology company will post earnings of $0.00 per share for the quarter. HC […]
